Feb 26, 2022
On this episode, we review the management of Crohn's Disease. We go over the newest guidelines and some of the supporting clinical data. We end by discussing the U.S. Preventive Services Task Force's colorectal cancer screening recommendations.
Once again, we’re excited to announce that our listeners can claim...
Feb 15, 2022
On this episode, we review the data for tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes a new medication that is being investigated. We discuss the unique mechanism of action and summarize...
Feb 7, 2022
On this episode, we review medication regimens for special patient populations. We start with a quick overview of CYP450 drug-drug interactions. We then discuss safety conerns when starting medications in a patient that is pregnant, is at an increase risk for a bleed, renal impairment, and hepatic impairment.
Once...